Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris
M Sullivan,
M Savvides,
S Abouantoun,
EB Madsen,
and
V Froelicher
Sixteen patients with stable angina pectoris were studied in a double blind crossover manner utilizing treadmill exercise testing with the direct measurement of total body oxygen uptake, 1 and 24 hours after application of a 20 cm2 transdermal nitroglycerin system and identical placebo. Testing was performed after a 3 day lead-in period of treatment with either an active patch or placebo. Points of analysis were peak angina and the submaximal work load occurring at 4 minutes of exercise. No statistically significant differences were observed between nitroglycerin and placebo treatment in any of the rest hemodynamic or peak angina variables at 1 or 24 hours. A significant increase in the rate-pressure product at the submaximal work load was observed 1 hour after transdermal nitroglycerin relative to placebo application. However, no significant differences were observed in any of the other measured variables at the submaximal work load, 1 or 24 hours after nitroglycerin application. The once daily application of a 20 cm2 transdermal nitroglycerin system was ineffective in altering the exercise capacity of patients with angina pectoris. The lack of efficacy at 1 hour appears to be due to inadequate nitroglycerin blood levels; at 24 hours it may be due to tolerance.
This article has been cited by other articles:
|
|
|
|
 
G. F. Fletcher, G. J. Balady, E. A. Amsterdam, B. Chaitman, R. Eckel, J. Fleg, V. F. Froelicher, A. S. Leon, I. L. Pina, R. Rodney, et al.
Exercise Standards for Testing and Training: A Statement for Healthcare Professionals From the American Heart Association
Circulation,
October 2, 2001;
104(14):
1694 - 1740.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. O. Parker, M. H. Amies, R. W. Hawkinson, J. M. Heilman, A. J. Hougham, M. C. Vollmer, and R. R. Wilson
Intermittent Transdermal Nitroglycerin Therapy in Angina Pectoris : Clinically Effective Without Tolerance or Rebound
Circulation,
March 1, 1995;
91(5):
1368 - 1374.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. F. Fletcher, G. Balady, V. F. Froelicher, L. H. Hartley, W. L. Haskell, and M. L. Pollock
Exercise Standards : A Statement for Healthcare Professionals From the American Heart Association
Circulation,
January 15, 1995;
91(2):
580 - 615.
[Full Text]
|
|
|
|
|
|
|
U. Elkayam
Tolerance to Organic Nitrates: Evidence, Mechanisms, Clinical Relevance, and Strategies for Prevention
Ann Intern Med,
April 15, 1991;
114(8):
667 - 677.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. K. Mahapatra, D. Mahapatra, and S. Yaden
Clinical Experience With a Transdermal Nitroglycerin System
Angiology,
April 1, 1987;
38(4):
277 - 286.
[Abstract]
[PDF]
|
|
|
|
|
|
|
U. THADANI, S. F. HAMILTON, E. OLSON, J. ANDERSON, W. VOYLES, R. PRASAD, and S. M. TEAGUE
Transdermal Nitroglycerin Patches in Angina Pectoris: Dose Titration, Duration of Effect, and Rapid Tolerance
Ann Intern Med,
October 1, 1986;
105(4):
485 - 492.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Thompson
Influence of Transdermal Nitrates on Exercise Capacity in Patients with Stable Angina
Angiology,
June 1, 1986;
37(6):
448 - 454.
[Abstract]
[PDF]
|
|
|
|
